| Positive Rankings |
Target Prices
The average analysts' target price is $100.00 for La Jolla Pharmaceutical Compan using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, La Jolla Pharmaceutical Compan is ranked 40. |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, La Jolla Pharmaceutical Compan is ranked 603. |
Debt-to-Equity
La Jolla Pharmaceutical Compan rank is 727 |
90 Day Gain
La Jolla Pharmaceutical Compan rank is 1001 |
10 Day Gain
La Jolla Pharmaceutical Compan rank is 2483 |
| Negative Rankings |
Negative ROE
La Jolla Pharmaceutical Compan rank is 214 |
Negative ROA
La Jolla Pharmaceutical Compan rank is 216 |
Price-to-Book
La Jolla Pharmaceutical Compan rank is 546 |
Negative Cash Growth
La Jolla Pharmaceutical Compan rank is 599 |
High Put/Call
La Jolla Pharmaceutical Compan has a high Put/Call ratio of 1.03 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Compan is ranked 662. |
High vPut/Call
La Jolla Pharmaceutical Compan has a high Put/Call ratio of 1.45 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Compan is ranked 806. |
Down EPS Surprise
La Jolla Pharmaceutical Compan missed the consensus earnings estimate when it last reported quarterly earnings. |
